Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis
Condition: Cystic Fibrosis Interventions: Drug: PTI-808; Drug: Placebo; Drug: PTI-801; Drug: PTI-428 Sponsor: Proteostasis Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cystic Fibrosis | Research